Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients. In some hepatitis C virus-infected patients, PEG-IFN plus RBV treatment against HCV s...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nepal Medical Association
2011-03-01
|
| Series: | Journal of Nepal Medical Association |
| Online Access: | http://jnma.com.np/jnma/index.php/jnma/article/view/44 |